Group | RT (n = 38) | RT + flumazenil (n = 38) | Propofol (n = 38) | RT (n = 38) | RT + flumazenil (n = 38) | Propofol (n = 38) | RT vs. RT + flumazenil | RT vs. Propofol | RT + flumazenil vs. Propofol |  |
---|---|---|---|---|---|---|---|---|---|---|
Time | Â | Least Square Mean Change | Estimated Difference | P value | ||||||
MMSE | ||||||||||
Preoperative | 27.47 ± 3.24 | 27.71 ± 2.40 | 27.28 ± 2.20 |  |  |  |  |  |  |  |
PACU | 27.66 ± 3.08 | 27.68 ± 2.31 | 27.22 ± 2.77 | 0.18 ± 0.23 | 0.00 ± 0.24 | -0.08 ± 0.24 | 0.18(-0.63-0.99) | 0.26(-0.55-1.08) | 0.08(-0.74-0.90) | 0.724 |
POD1 | 28.45 ± 2.61 | 28.21 ± 1.91 | 27.56 ± 2.45 | 0.58 ± 0.16 | 0.24 ± 0.16 | 0.11 ± 0.17 | 0.34(-0.21-0.90) | 0.47(-0.10-1.03) | 0.13(-0.44-0.69) | 0.117 |
VAS | ||||||||||
Preoperative | 0.00 ± 0.00 | 0.11 ± 0.65 | 0.00 ± 0.00 |  |  |  |  |  |  |  |
PACU | 1.33 ± 1.55 | 1.44 ± 1.65 | 1.53 ± 1.94 | 1.33 ± 1.55 | 1.53 ± 1.94 | 1.33 ± 1.53 | -0.20(-0.97-0.57) | -0.01(-0.80-0.77) | -0.18(-0.97-0.60) | 0.853 |
POD1 | 0.63 ± 1.05 | 0.89 ± 1.10 | 1.03 ± 1.48 | 0.63 ± 1.05 | 1.03 ± 1.48 | 0.78 ± 1.35 | -0.40(-0.95-0.16) | -0.28(-0.85-0.29) | -0.11(-0.68-0.46) | 0.356 |
PostopQRS | ||||||||||
Preoperative | 65.74 ± 3.47 | 66.05 ± 3.63 | 65.72 ± 3.17 |  |  |  |  |  |  |  |
POD1 | 65.61 ± 3.76 | 64.39 ± 2.95 | 65.03 ± 3.42 | -0.17 ± 0.43 | -1.58 ± 0.43 | -0.74 ± 0.44 | 1.41(-0.07-2.89) | 0.57(-2.07-0.93) | -0.84(-2.34-0.66) | 0.072 |
POD14 | 65.31 ± 2.76 | 65.30 ± 3.01 | 65.74 ± 2.74 | -0.33 ± 0.30 | -1.01 ± 0.30 | -0.55 ± 0.32 | 0.68(-0.34-1.69) | 0.22(-0.84-1.27) | -0.46(-1.51-0.59) | 0.264 |
Telephone Interview for Cognitive Status | ||||||||||
POD14 | 33.16 ± 3.54 | 32.85 ± 3.86 | 32.00 ± 4.15 |  |  |  |  |  |  | 0.500 |